In its earnings release posted earlier this month, Herbalife revealed the preliminary results of its beta launch of the Pro2col health and wellness digital platform. Herbalife acquired 100% of the assets of Pro2col Health LLC and Pruvit Ventures, Inc. in March, stating that leveraging the new technology would expand its customer base and accelerate its vision to modernize the Herbalife business.
Since its beta rollout in July at the North America Extravaganza, more than 7,000 distributors engaged with the platform. From those 7,000 participants, the company has already collected what it calls “hundreds of thousands” of data points, from basic information like gender, age and nutritional goals to more complex data like sleep quality and anxiety levels. The app has also tracked product usage and wellness activities, like cold plunges and meditation. In a conversation with podcast host Shawn Severson of Water Tower Research, Herbalife Chief Financial Officer John DeSimone teased that the biomarker beta testing will eventually extend to include blood or stool samples.
“Based on that data in each customer’s personal goal, the app can suggest targeted product solutions that drive engagement, boost sales, and we believe it will improve retention and ultimately increase lifetime value of the customer,” DeSimone said. “You can envision the power of this data when it becomes operational commercialized both not in the US but hopefully over time, globally.”
The company said that it “looks forward to gathering valuable feedback from distributors ahead of the commercial release in the U.S. and Puerto Rico,” which is scheduled to take place during the fourth quarter of 2025. Additional markets are planned for the beginning of 2026.
This beta unveiling of the AI-assisted Pro2col app, in tandem with the launch of MultiBurn – a next-generation, multi-action weight loss supplement featuring clinically studied botanical extracts – helped the company deliver solid second quarter results and raise its full-year net sales and adjusted EBITDA guidance.
Next year, the company plans to launch unique product formulations designed to deliver nutrition directly informed by data collected from each app user. These products would not be mass produced, one-size-fits-all formulations, but rather one product, one formula for one individual.
“We’re taking bold steps that reinforce our commitment to innovation, transformative growth and long-term value creation,” said Stephen Gratziani, Herbalife CEO.